---
title: "688658.SH (688658.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688658.SH/news.md"
symbol: "688658.SH"
name: "688658.SH"
parent: "https://longbridge.com/en/quote/688658.SH.md"
datetime: "2026-05-21T00:54:23.149Z"
locales:
  - [en](https://longbridge.com/en/quote/688658.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688658.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688658.SH/news.md)
---

# 688658.SH (688658.SH) — Related News

### [With a billion investment in Hangzhou Pharmaceutical Port, can YKYY secure its position in the nucleic acid new drug track?](https://longbridge.com/en/news/287018709.md)
*2026-05-20T06:37:37.000Z*
> YKYY invested 1 billion yuan in the Hangzhou Pharmaceutical Port to build a nucleic acid drug base, marking its transfor

### [Performance has declined for four consecutive years, YKYY plans a 1 billion layout in nucleic acid for transformation](https://longbridge.com/en/news/286524089.md)
*2026-05-15T07:14:11.000Z*
> YKYY announced an investment of 1 billion yuan to build a nucleic acid drug base, aimed at addressing the challenges of 

### [YKYY splurges 1 billion to build nucleic acid project to bet on the future; dual-price drug price reduction leads to a loss of 262 million](https://longbridge.com/en/news/286189351.md)
*2026-05-13T03:00:28.000Z*
> YKYY announced an investment of 1 billion yuan to build a nucleic acid drug base project, establishing nucleic acid drug

### [The innovative drug and chemical pharmaceutical sectors continued to strengthen in the afternoon, with stocks like PKU HEALTHCARE hitting the daily limit](https://longbridge.com/en/news/282787254.md)
*2026-04-15T05:24:59.000Z*
> The innovative drug and chemical pharmaceutical sectors continued to strengthen in the afternoon, with PKU HEALTHCARE, S

### [YKYY: Subsidiary YKYY026 injection for the prevention of shingles clinical trial application approved](https://longbridge.com/en/news/282518283.md)
*2026-04-13T09:34:55.000Z*
> YKYY's subsidiary has received approval from the National Medical Products Administration to conduct Phase I clinical tr

### [YKYY: Ultra-long-acting antihypertensive innovative drug YKYY029 injection Phase II clinical trial launched](https://longbridge.com/en/news/282415708.md)
*2026-04-11T11:53:43.000Z*
> YKYY Pharmaceuticals announced that the Phase II clinical trial of the ultra-long-acting antihypertensive drug YKYY029 i

### [](https://longbridge.com/en/news/281590494.md)
*2026-04-03T01:07:09.000Z*
> State Grid's fixed asset investment in the first quarter approached 130 billion yuan. The Ministry of Industry and Infor

### [The subsidiary of YKYY, YKYY018, has received approval for clinical trials for the treatment and prevention of human metapneumovirus infection](https://longbridge.com/en/news/281505347.md)
*2026-04-02T10:22:07.000Z*
> YKYY's wholly-owned subsidiary, Beijing YKYY Technology Co., Ltd., has received approval from the National Medical Produ